Company / Return on Assets (ROA)
Gilead Sciences Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
14.4%
FY2025
5-year range
0.2% / 14.4%
FY2021-FY2025
Trend
+1680.2%
vs FY2024
Sector context
#20 of 213
Health Care
What the data says
Return on Assets (ROA) changed +1680% YoY in FY2025, a notable deviation from the 9-year average annual change of +1201%.
Based on SEC 10-K filings.
14.4% in FY2025 with a 5-year CAGR of +14.2%. Top quartile in the Health Care sector.
Improved from 10.0% to 14.4% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +14.2pp
- 5-Year Change
- +14.2pp
- 10-Year Change
- -
Sector benchmark
Top 9% in Health CareTop 9% of 213This company 14.4% Sector average -24.1%
▼
+159.7% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 1680.2% year-over-year.
- Currently 38.6pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2017.
- Lowest return on assets (roa) in the period was in FY2020.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 14.4% | +1680.2% |
| FY2024 | 0.8% | -91.9% |
| FY2023 | 10.0% | +5173.7% |
| FY2022 | 0.2% | -97.6% |
| FY2021 | 7.9% | +4305.6% |
| FY2020 | 0.2% | -97.6% |
| FY2019 | 7.5% | -64.6% |
| FY2018 | 21.2% | -17.7% |
| FY2017 | 25.8% | +21.3% |
| FY2016 | 21.2% | -39.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026